24282248

Li Y

2013

Letrozole, berberine, or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a double-blind randomised controlled trial.

24283067

Gateva A

2013

[Polycystic ovarian syndrome and obstructive sleep apnea].

24283075

Kostov I

2013

[In vitro maturation--a potential approach of infertility treatment of patients with PCOS].

24283091

Ugwu GO

2013

Prevalence, presentation and management of polycystic ovary syndrome in Enugu, south east Nigeria.

24285770

Lyster RL

2013

Abnormal vaginal bleeding following pharmacist prescribing of metformin leads to the detection of complex endometrial hyperplasia.

24286956

Nandi A

2013

Diabetes and the female reproductive system.

24287819

Saller S

2014

Dopamine in human follicular fluid is associated with cellular uptake and metabolism-dependent generation of reactive oxygen species in granulosa cells: implications for physiology and pathology.

24287894

Richardson MC

2014

Environmental and developmental origins of ovarian reserve.

24290002

Shehata IA

2014

High-intensity focused ultrasound for potential treatment of polycystic ovary syndrome: toward a noninvasive surgery.

24294740

Parahuleva N

2013

[Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].

24295815

Dileepan K

2013

Type 2 diabetes mellitus in children and adolescents.

24299151

Luo S

2014

Effect of gonadotropin-releasing hormone antagonists on intrauterine insemination cycles in women with polycystic ovary syndrome: a meta-analysis.

24299606

Ehling D

2013

Integrative techniques using acupuncture, Chinese herbal medicine, diet, and supplements for polycystic ovary syndrome: a case report.

24302747

Li Q

2014

A possible new mechanism in the pathophysiology of polycystic ovary syndrome (PCOS): the discovery that leukocyte telomere length is strongly associated with PCOS.

24303884

Tian X

2014

Anti-M?llerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China.

24308745

B?ttcher B

2014

Dynamics of anti-M?llerian hormone during controlled ovarian stimulation.

24308752

Bazarganipour F

2014

Health-related quality of life in patients with polycystic ovary syndrome (PCOS): a model-based study of predictive factors.

24319557

Mehrabian F

2013

Can Sex-hormone Binding Globulin Considered as a Predictor of Response to Pharmacological Treatment in Women with Polycystic Ovary Syndrome?

24320038

Katsiki N

2014

Metabolic syndrome and non-cardiac vascular diseases: an update from human studies.

24322653

Orio F

2014

Reproductive endocrinology: New guidelines for the diagnosis and treatment of PCOS.

24323131

Osman NI

2014

Fowler's syndrome--a cause of unexplained urinary retention in young women?

24323736

Kothari R

2014

2D:4D ratio in children at familial high-risk for eating disorders: The role of prenatal testosterone exposure.

24324025

West S

2014

The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966.

24324038

Luque-Ram?rez M

2014

Office blood pressure, ambulatory blood pressure monitoring, and echocardiographic abnormalities in women with polycystic ovary syndrome: role of obesity and androgen excess.

24325993

Panidis D

2014

Uterine volume and endometrial thickness in the early follicular phase in patients with polycystic ovary syndrome.

24326560

Ishak RS

2013

Association between alopecia areata, psoriasis vulgaris, thyroid disease, and metabolic syndrome.

24327994

Kim JJ

2013

Dyslipidemia in women with polycystic ovary syndrome.

24328010

Kim JJ

2013

Carotid intima-media thickness in mainly non-obese women with polycystic ovary syndrome and age-matched controls.

24328568

Sahmay S

2014

Relation of antimullerian hormone with the clinical signs of hyperandrogenism and polycystic ovary morphology.

24330637

Karimzadeh L

2013

Effect of bee venom on IL-6, COX-2 and VEGF levels in polycystic ovarian syndrome induced in Wistar rats by estradiol valerate.

24334867

Grech I

2014

Impact of TNF haplotypes in the physical course of acne vulgaris.

24335000

Yang Z

2014

Association between adiponectin receptor 1 gene polymorphism and insulin resistance in Chinese patients with polycystic ovary syndrome.

24336678

Yang M

2014

Increased expression of kindlin 2 in luteinized granulosa cells correlates with androgen receptor level in patients with polycystic ovary syndrome having hyperandrogenemia.

24337962

Li HW

2014

Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment.

24340639

Dubinskaia ED

2013

[Role of the genetic factors, detoxication systems and oxidative stress in the pathogenesis of endometriosis and infertility (review)].

24341292

Amer SA

2013

The influence of circulating anti-M?llerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study.

24341398

Holbrey S

2013

A qualitative investigation of the impact of peer to peer online support for women living with polycystic ovary syndrome.

24342177

d'Herbomez M

2014

[Biomarkers in endocrinology].

24343036

Sahmay S

2014

Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms.

24343052

Nemcovich J

2014

Letter to the editor.

24343062

Hu WH

2013

[Expression of PPAR? mRNA in granulosa cells and its correlation with clinical characteristics of polycystic ovary syndrome].

24343068

Xu YY

2013

[Analysis of clinical factors affecting pregnancy rate of intrauterine insemination].

24343626

Caldas D

2013

[Biochemical, hormonal and genetic evaluation of the families of two Brazilian patients with type 2 familial partial lipodystrophy].

24345067

Fulghesu AM

2014

Ovulation induction in young girls with menometrorragia: a safe and effective treatment.

24345626

El-Kannishy G

2010

Endothelial function in young women with polycystic ovary syndrome (PCOS): Implications of body mass index (BMI) and insulin resistance.

24345633

Dewailly D

2014

Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.

24347428

Tosi F

2014

Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome.

24348019

Hajishafiha M

2013

Combined letrozole and clomiphene versus letrozole and clomiphene alone in infertile patients with polycystic ovary syndrome.

24351071

Tu J

2014

A novel modified ultra-long agonist protocol improves the outcome of high body mass index women with polycystic ovary syndrome undergoing IVF/ICSI.

24351072

Pizzo A

2014

Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.

24353659

Mohammadbygi R

2013

Effects of Cabergoline administration on uterine perfusion in women with polycystic ovary syndrome.

24355046

Reichman DE

2014

Fertility in patients with congenital adrenal hyperplasia.

24360136

Algars M

2014

Binge eating and menstrual dysfunction.

24362411

Jensterle Sever M

2014

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin.

24368020

Shi Y

2014

Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors.

24368231

Murri M

2014

Metabolomics in polycystic ovary syndrome.

24371816

Wang Y

2013

Risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndrome.

24376410

Gibson EL

2013

Habitual fat intake predicts memory function in younger women.

24377044

Demir M

2013

Retinal nerve fiber layer thickness in women with polycystic ovary syndrome.

24379345

Wu S

2014

Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell.

24379699

Sirmans SM

2013

Epidemiology, diagnosis, and management of polycystic ovary syndrome.

24379837

Mehrabian F

2013

Sex hormone binding globulin measurement before conception as a predictor of gestational diabetes in women with polycystic ovarian syndrome.

24382375

Hillman JK

2014

Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected].

24384023

Hoeger KM

2014

A patient's guide: polycystic ovary syndrome (PCOS).

24387273

Palomba S

2014

Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials.

24388959

Lam UD

2014

Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.

24389146

Barthelmess EK

2014

Polycystic ovary syndrome: current status and future perspective.

24389875

Sokalska A

2014

Comparison of effects of different statins on growth and steroidogenesis of rat ovarian theca-interstitial cells.

24390359

McCook JG

2015

Differential Contributions of Polycystic Ovary Syndrome (PCOS) Manifestations to Psychological Symptoms.

24390626

Roth LW

2014

Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome.

24390680

Wu XQ

2014

Association between FSHR polymorphisms and polycystic ovary syndrome among Chinese women in north China.

24391413

Makedos A

2011

Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome.

24391762

Cai L

2013

Effects of upregulation of Hsp27 expression on oocyte development and maturation derived from polycystic ovary syndrome.

24392647

Orlik B

2014

Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome.

24397393

Haoula Z

2014

Validation of proteomic biomarkers previously found to be differentially expressed in women with polycystic ovary syndrome: a cross-sectional study.

24397396

Rutkowska A

2014

Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS).

24401089

Aye MM

2014

Postprandial effects of long-term niacin/laropiprant use on glucose and lipid metabolism and on cardiovascular risk in patients with polycystic ovary syndrome.

24403767

Narad S

2013

Hormonal profile in Indian men with premature androgenetic alopecia.

24404360

Allameh Z

2013

Does Carotid Intima-media Thickness have Relationship with Polycystic Ovary Syndrome?

24405081

Palomba S

2014

Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review.

24405633

Li X

2014

Endometrial progesterone resistance and PCOS.

24408363

Ressler IB

2014

Metabolic, behavioral, and reproductive effects of vertical sleeve gastrectomy in an obese rat model of polycystic ovary syndrome.

24410809

Zhang CM

2014

Metabolic heterogeneity of follicular amino acids in polycystic ovary syndrome is affected by obesity and related to pregnancy outcome.

24411130

Rashidi H

2014

To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran.

24411638

Campos DB

2015

Relationship between adiponectin and fertility in the female pig.

24414393

Li S

2014

Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis.

24418062

Naver KV

2014

Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia.

24419495

K?ninger A

2014

Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.

24419531

Moreira Sda N

2013

[Quality of life and psychosocial aspects of polycystic ovary syndrome: a quali-quantitative approach].

24423322

Bhatt S

2014

The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome.

24423336

Stridsklev S

2014

Midpregnancy Doppler ultrasound of the uterine artery in metformin- versus placebo-treated PCOS women: a randomized trial.

24423344

O'Reilly MW

2014

Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.

24424368

Sung YA

2014

Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome.

24425206

Wang YX

2014

Expression of PPAR-? in adipose tissue of rats with polycystic ovary syndrome induced by DHEA.

24425466

Yeo L

2014

Treatment of acne in children.

24428203

Zhao X

2014

Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry.

24428207

Hosseinpanah F

2014

Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study.

24430093

Berberoglu Z

2015

Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome.

24430863

Dewailly D

2014

The physiology and clinical utility of anti-Mullerian hormone in women.

24434230

Sanad AS

2014

Prevalence of polycystic ovary syndrome among fertile and infertile women in Minia Governorate, Egypt.